b 4162 has been researched along with 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole in 1 studies
Studies (b 4162) | Trials (b 4162) | Recent Studies (post-2010) (b 4162) | Studies (1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole) | Trials (1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole) | Recent Studies (post-2010) (1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole) |
---|---|---|---|---|---|
50 | 1 | 0 | 290 | 0 | 104 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andoh, T; Kuraishi, Y | 1 |
1 other study(ies) available for b 4162 and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole
Article | Year |
---|---|
Quantitative determination of endogenous nitric oxide in the mouse skin in vivo by microdialysis.
Topics: Animals; Benzoates; Bradykinin; Bradykinin Receptor Antagonists; Enzyme Inhibitors; Imidazoles; Male; Mice; Mice, Inbred ICR; Microdialysis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Receptor, Bradykinin B2; Skin | 1997 |